Validation of rAAV-focused commercial opportunities

Lead Research Organisation: University of Edinburgh
Department Name: Biomedical Sciences

Abstract

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

Publications

10 25 50
 
Description We commissioned a market research report and an intellectual property report to address the feasibility of developing a business service for proving viral vectors for pre-clinical or clinical research. The market research report identified strong unmet pre-clinical demand and relatively low barriers to entering the market. The report identified a pathway to further develop the business idea. The intellectual property report indicated that key patents in the area are expired giving considerable freedom to operate. It also identified areas for future exploration and clarification.
Exploitation Route The results of the Pathfinder led us to focus on developing a local viral vector core facility, which is now fully operational, and collaboration with a biotech Synpromics. This collaboration has been supported by funding from IBioIC.
Sectors Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology

 
Description The study led us to focus on developing of external collaborations, which led to an IBioIC award with Synpromics.
First Year Of Impact 2016
Sector Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology
 
Description BBSRC funding committee A
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
 
Description BBSRC funding committee A
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
 
Description New York Academy of Sciences - Takeda Innovator Award jury member
Geographic Reach Multiple continents/international 
Policy Influence Type Participation in a advisory committee
 
Description Wellcome Trust funding panel
Geographic Reach National 
Policy Influence Type Participation in a advisory committee
 
Description Synthetic Biology Accelerator grant.
Amount £245,589 (GBP)
Organisation IBioIC 
Sector Academic/University
Country United Kingdom
Start 03/2017 
End 02/2019
 
Description Collaboration with Synpromics 
Organisation Synpromics
Country United Kingdom 
Sector Private 
PI Contribution Synpromics is a biotech company specialising in engineering synthetic promoters. We have established a collaboration with Synpromics to develop virus-based tools for them using technologies we have developed as part our ongoing and previous projects.
Collaborator Contribution See above. For commercial reasons specific details of the project are confidential.
Impact The collaboration is in progress. It is too early to report outputs.
Start Year 2016